18717796589
首頁
日本名醫
日本醫院
先端醫療
診療科室
日本醫訊
首頁
日本名醫
日本醫院
先端醫療
診療科室
日本醫訊
快速導航
療法概述
瀨田診所
流程與費用
證據文獻
案例與效果
瀨田訪談
免疫療法基礎知識
視頻講座
免疫療法基礎知識
新世代細胞?免疫治療研究室
證據文獻
NO
論文
登載期刊
PM ID
全文鏈接
中文鏈接
1
輔助免疫細胞療法與全身系統性療法結合治療實體瘤的療效
Anticancer Research 42: 4179-4187 / 2022
35896218
https://ar.iiarjournals.org/content/42/8/4179
http://www.vpaidu.com/laitian/results/22.html
2
食管癌對免疫細胞療法和低劑量納武單抗聯合治療有反應
Journal of Medical Case Reports 15, Article number: 191 / 2021
33827668
https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-020-02634-z
http://www.vpaidu.com/laitian/results/23.html
3
免疫細胞療法治療晚期/復發性乳腺癌的預后因素
Anticancer Research 41:4133-4141 / 2021
34281884
https://ar.iiarjournals.org/content/41/8/4133.long
http://www.vpaidu.com/laitian/results/1.html
4
過繼性T細胞免疫治療對晚期胰腺癌患者免疫學指標及預后的影響
CYTOTHERAPYFeb;23(2):137-145/2020
32907781
https://linkinghub.elsevier.com/retrieve/pii/S1465-3249(20)30813-6
http://www.vpaidu.com/laitian/results/2.html
5
接受一線化療免疫治療的轉移性結直腸癌患者的免疫狀態變化
Anticancer Research 40:4763-4771 / 2020
32727803
https://ar.iiarjournals.org/content/40/8/4763.long
http://www.vpaidu.com/laitian/results/3.html
6
過繼免疫細胞治療子宮頸神經內分泌癌
Anticancer Research 40:4741-4748 / 2020
32727800
https://ar.iiarjournals.org/content/40/8/4763
http://www.vpaidu.com/laitian/results/4.html
7
免疫細胞治療子宮內膜癌和宮頸癌預后因素的回顧性研究
Anticancer Research 40:4729-4740 / 2020
32727799
https://ar.iiarjournals.org/content/40/8/4729.long
http://www.vpaidu.com/laitian/results/5.html
8
適應性免疫細胞治療對晚期胃癌患者免疫細胞譜的影響
Cancer Med 9(14):4907-4917 / 2020
32529780
https://ar.iiarjournals.org/content/40/8/4729.long
http://www.vpaidu.com/laitian/results/6.html
9
γδT細胞免疫治療實體瘤預后因素的研究
CYTOTHERAPY Jun;22(6):329-336 / 2020
32303429
https://pubmed.ncbi.nlm.nih.gov/32303429/
http://www.vpaidu.com/laitian/results/7.html
10
免疫細胞聯合一線化療治療結直腸癌的預后因素:一項回顧性研究
Anticancer Research 39: 4525-4532 / 2019
31366555
https://pubmed.ncbi.nlm.nih.gov/31366555/
http://www.vpaidu.com/laitian/results/8.html
11
免疫細胞治療胰腺癌患者的預后因素
Anticancer Research 38 (7) 4353-4360 / 2018
29970573
https://pubmed.ncbi.nlm.nih.gov/29970573/
http://www.vpaidu.com/laitian/results/9.html
12
腫瘤內注射唑來膦酸鹽沖擊樹突狀細胞、靜脈過繼活化T淋巴細胞和吉西他濱聯合綜合免疫治療不可切除的局部晚期胰腺癌的I/II期臨床研究
Oncotarget Dec5;9(2):2838-2847./2017
29416816
https://pubmed.ncbi.nlm.nih.gov/29416816/
http://www.vpaidu.com/laitian/results/10.html
13
全身靜脈過繼轉移自體淋巴因子激活的αβT細胞改善替莫唑胺誘導的膠質瘤患者淋巴細胞減少
Anticancer Research Jul;37(7):3921-3932./2017
28668896
https://pubmed.ncbi.nlm.nih.gov/28668896/
http://www.vpaidu.com/laitian/results/11.html
14
過繼免疫聯合化療治療IV期結直腸癌的臨床研究(COMVI研究)
Anticancer Research Jul;37(7):3941-3946. / 2017
28668898
https://pubmed.ncbi.nlm.nih.gov/28668898/
http://www.vpaidu.com/laitian/results/12.html
15
過繼免疫細胞療法治療晚期胃癌的回顧性研究
Anticancer Research Jul;37(7):3947-3954. / 2017
28668899
https://pubmed.ncbi.nlm.nih.gov/28668899/
http://www.vpaidu.com/laitian/results/13.html
16
mRNA-EP制備的腫瘤血管靶向CAR-T細胞用于臨床研究的免疫學質量和性能
Mol Ther Oncolytics.Nov 16;3:16024. / 2016
27909701
https://pubmed.ncbi.nlm.nih.gov/27909701/
http://www.vpaidu.com/laitian/results/14.html
17
活化αβT細胞過繼免疫化療治療IV期結直腸癌
Anticancer Research Jul;36(7):3741-6. / 2016
27354648
https://pubmed.ncbi.nlm.nih.gov/27354648/
http://www.vpaidu.com/laitian/results/15.html
18
WT1抗原在多種實體癌細胞中表達的免疫組織化學分析
Anticancer Research 36(7):3715-3724 / 2016
27354645
https://pubmed.ncbi.nlm.nih.gov/27354645/
http://www.vpaidu.com/laitian/results/16.html
19
自體免疫細胞治療改善不同類型晚期癌癥患者的免疫功能受損
Anticancer Research 36(7):3715-3724 / 2016
26168498
https://pubmed.ncbi.nlm.nih.gov/26168498/
http://www.vpaidu.com/laitian/results/17.html
20
免疫細胞治療在不同類型晚期癌癥患者中的前瞻性安全性評價
Anticancer Research 35(8):4535-4543 / 2015
25075106
https://pubmed.ncbi.nlm.nih.gov/25075106/
http://www.vpaidu.com/laitian/results/18.html
21
在晚期癌癥患者中評估細胞免疫狀態受損和失衡,并通過過繼性T細胞免疫治療恢復T細胞免疫狀態
International Immunopharmacology18(1):90-97. / 2014
24269583
https://pubmed.ncbi.nlm.nih.gov/24269583/
http://www.vpaidu.com/laitian/results/19.html
22
封閉流式電穿孔系統治療實體瘤的自體腫瘤溶解物樹突狀細胞疫苗免疫治療
Anticancer Research 33(7):2971-6. / 2013
23780988
https://pubmed.ncbi.nlm.nih.gov/23780988/
http://www.vpaidu.com/laitian/results/20.html
23
晚期肺癌過繼性活化T淋巴細胞免疫治療中觀察到的生存期延長:一項多中心歷史性隊列研究的結果
Cancer Immunology, Immunotherapy 61:1781-1790. / 2012
22422103
https://pubmed.ncbi.nlm.nih.gov/22422103/
http://www.vpaidu.com/laitian/results/21.html